NEWARK, DE | The nasal mucosa therapeutics market surpassed USD 5.0 billion in 2025 and is projected to reach USD 5.9 billion in 2026, expanding at a CAGR of 18.3% through 2036. By the end of the forecast period, the market is expected to achieve a valuation of USD 31.7 billion, driven by advanced formulations that bypass hepatic first-pass metabolism and enable rapid systemic...